|
|
||||||||
Ann Thorac Surg 2007;83:1002-1006
© 2007 The Society of Thoracic Surgeons
a Department of Surgery, St. Johns Mercy Medical Center, St. Louis, Missouri
b Duke Clinical Research Institute, Durham, North Carolina
c Department of Cardiovascular-Thoracic Surgery, Rush University, Chicago, Illinois
d Department of Medicine, Duke University, Durham, North Carolina
e Department of Surgery, University of Florida, Jacksonville, Florida
Accepted for publication September 28, 2006.
* Address correspondence to Dr Savage, 621 S. New Ballas Rd, Suite R-7049, 625 South New Ballas Rd, St. Louis, MO 63141 (Email: chstcutter{at}aya.yale.edu).
| Abstract |
|---|
|
|
|---|
Methods: Diabetic patients who had isolated coronary artery bypass graft surgery during 2002 to 2004 were included if they had no prior bypass surgery, two or more distal bypasses, and a left internal thoracic artery bypass. Group B (both internal thoracic arteries) was compared with group L (left internal thoracic artery only).
Results: The incidence of deep sternal wound infection for all patients undergoing isolated first-time bypass surgery was less than 1%. Of these, 120,793 patients met criteria for inclusion: group B, 1.4% (1732); and group L, 98.6% (119,061). Group B had a higher crude (unadjusted) deep sternal wound infection rate of 2.8% (49) versus 1.7% (1969; p = 0.0005) in group L, with an estimated odds ratio of 2.23 (95% confidence interval, 1.69 to 2.96). Group B had a similar crude mortality rate of 1.7% (30) versus 2.3% (2785; p = NS) in group L, with an estimated odds ratio of 1.110 (95% CI, 0.78 to 1.59; p = NS). Patients in group B were younger, mostly male, had a lower serum creatinine level, and were more often current smokers; less commonly, they were insulin dependent, diagnosed with pulmonary or vascular disease, or on dialysis. Other risk factors for deep sternal would infection included female gender, insulin dependence, peripheral vascular disease, recent infarction, body mass index exceeding 35 kg/m2, and use of blood products.
Conclusions: There is a significant increase in the incidence of deep sternal would infection in diabetic patients. This is further increased with the use of both internal thoracic arteries with no apparent short-term mortality difference.
| Introduction |
|---|
|
|
|---|
Numerous studies have shown that the use of both internal thoracic arteries increases long-term survival relative to the use of the left internal thoracic artery and saphenous vein grafts [79]. Use of two internal thoracic arteries is increasingly recommended either as bilateral pedicled grafts, free grafts from the aorta, or as a composite graft, which is a free graft originating off a pedicled graft as an extension or in a branched configuration. However, the concern that diabetes leads to an increased risk of DSWI has limited the use of both internal thoracic arteries to nondiabetic patients. This may lead to the denial of the long-term benefits of the use of both internal thoracic arteries from diabetic patients.
We sought to answer three questions based on the large amount of information available from the STS National Cardiac Database:
| Material and Methods |
|---|
|
|
|---|
Patient Population
A subset of diabetic patients who underwent isolated CABG surgery during 2002 to 2004 was included in this study. Records during this time span were included only if collected on versions 2.41 or 2.52 of the standard data collection form to ensure consistency in the data definitions. Patients with prior CABG surgery, fewer than two distal anastomoses, without diabetes, or those whose procedure did not involve use of the left internal thoracic artery were excluded from analysis. Patients in whom both internal thoracic arteries (group B) were used were compared with those in whom only the left internal thoracic artery (group L) was used.
Clinical End Point
The primary end point was the diagnosis of a DSWI. The secondary end point was operative mortality, defined as death occurring during the hospitalization in which the operation was performed, even if after 30 days; or death occurring after discharge from the hospital, but within 30 days of the procedure, unless the cause of death was clearly unrelated to the operation.
Statistical Analysis
Group B patients were compared with group L patients for the two outcome variables of DSWI and operative mortality. Univariable differences between the two groups were assessed using generalized score tests that account for clustering of study subjects within hospitals. Adjusted odds ratios comparing group B with group L were estimated by fitting separate logistic regression models for DSWI and operative mortality. Predictor variables were identified from previous STS risk-prediction models for DSWI and clinical judgement. The parameters of the logistic regression model were estimated by using generalized estimating equations methodology to adjust for correlation between patient outcomes within the same hospital or surgeon group.
| Results |
|---|
|
|
|---|
|
|
|
|
| Comment |
|---|
|
|
|---|
By its nature, the database only allows retrospective analysis, and data sets may be incomplete. Although theoretically possible, "going back" to seek a more complete data set or make additional comparisons is not practical. Instead, questions that cannot be answered by the current data set (eg, Was the internal thoracic artery skeletonized? or How tightly were glucose level controlled perioperatively?) are more practically incorporated into future data sets.
The definition of DSWI is another limitation of the STS database. DSWI represents a spectrum of illness, from a sternitis to profound mediastinitis with associated sepsis, but no data are available to stratify the severity of the infection.
A final important limitation is that no long-term survival data are currently available within the database to assess the overall impact of the use of one or both internal thoracic arteries. We are thus limited in the questions that can be answered by the current study, but this study will help guide future data collection.
The improved durability and survival benefit of multiarterial grafting has been clearly demonstrated. This is best documented with the use of both internal thoracic arteries [13]. Within the past 10 years, however, the use of the radial artery as a free graft has gained popularity. Whether the free radial graft will be as durable as a pedicled internal thoracic artery graft is unanswered. An important variable in the selection of a conduit for multiarterial grafting is the associated morbidity. Very few major complications have been reported with proper use of the free radial artery [14]. In contrast, the use of both internal thoracic arteries has been associated with a higher incidence of sternal wound infection [15].
Gansera and colleagues [6] compared outcomes in 4462 patients in which both internal thoracic arteries were used with 4204 patients in which a single internal thoracic artery was used. They noted that in all patients, the use of both internal thoracic arteries increased the incidence of sternal instability (1.4% versus 0.6%) and mediastinitis (0.7% versus 0.2%). The incidence of mediastinitis in diabetic patients increased to 1.0% with use of both and 0.2% with a single internal thoracic artery. Gansera and colleagues [6] present important results from one center, but they do not represent results noted in general practice; their incidence of DSWI in diabetic patients is significantly lower than that reported in the STS database.
This study sought to assess the relationship and impact of diabetes and the use of both internal thoracic arteries through the unique size and capacity of the STS database. Diabetes is an independent risk factor for the development of a deep sternal wound infection; in this study, it was 0.66% for nondiabetic patients versus 1.7% for those with diabetes. The use of both internal thoracic arteries further increases this risk in diabetic patients, 1.7% with the use of one versus 2.8% with the use of both internal thoracic arteries. There was no associated increase in short-term mortality.
These data should be interpreted with caution, because the diabetic group in which both internal thoracic arteries were used had fewer risk factors for morbidity and mortality than the other group and may have been able to better endure and survive a DSWI. Internal thoracic artery usage may reflect the bias of surgeons who are less likely to use both internal thoracic arteries in patients who are older, obese, and insulin-dependent, with pulmonary, renal, or vascular disease.
Skeletonization of the internal thoracic artery, defined here as dissection leaving the muscle attached to the chest wall, thus minimizing sternal devascularization, compared with removal with an attached muscle pedicle, might reduce the risk of DSWI. Khuri [16] recently reviewed results of the use of skeletonization and noted that nonrandomized observational studies suggest that skeletonization results in less reduction of sternal perfusion and an associated reduction in sternal wound infection, but no randomized studies have been reported to date [17, 18]. Although this information would be useful and informative, it cannot be determined for this patient group because it was not collected as part of the data set.
Furnary and colleagues [19] have shown that aggressive use of insulin for perioperative glucose control greatly reduces mortality and infectious complications. Whether better treatment of diabetes perioperatively would lessen the difference between the two groups studied here is unknown. Data on perioperative glucose control are not available for the data set analyzed. This is an important area for future investigation.
According to these results, the diagnosis of diabetes mellitus should not preclude the use of both internal thoracic arteries. The increase in the risk of DSWI, in the absence of an associated increased short-term mortality risk, does not justify routine denial of the long-term mortality benefit potentially derived from the use of both internal thoracic arteries. There is, however, clear evidence that the use of both internal thoracic arteries in diabetic patients at particular risk for DSWI, specifically women and those with insulin dependence, vascular disease, recent myocardial infarction and excessive body mass index, may not be indicated and alternative arterial grafts may be a better option.
| References |
|---|
|
|
|---|
Related Article
This article has been cited by other articles:
![]() |
M. Tabata, J. D. Grab, Z. Khalpey, F. H. Edwards, S. M. O'Brien, L. H. Cohn, and R. M. Bolman III Prevalence and Variability of Internal Mammary Artery Graft Use in Contemporary Multivessel Coronary Artery Bypass Graft Surgery: Analysis of the Society of Thoracic Surgeons National Cardiac Database Circulation, September 15, 2009; 120(11): 935 - 940. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Z. Atkins, M. K. Wooten, J. Kistler, K. Hurley, G. C. Hughes, and W. G. Wolfe Does Negative Pressure Wound Therapy Have a Role in Preventing Poststernotomy Wound Complications? Surgical Innovation, June 1, 2009; 16(2): 140 - 146. [Abstract] [PDF] |
||||
![]() |
Y. Ishii, S.-i. Sakamoto, R. T. Kronengold, R. Virmani, E. A. Rivera, S. M. Goldman, E. J. Prechtel, J. G. Hill, and R. J. Damiano Jr. A novel bioengineered small-caliber vascular graft incorporating heparin and sirolimus: Excellent 6-month patency. J. Thorac. Cardiovasc. Surg., June 1, 2008; 135(6): 1237 - 1246. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Nakano, H. Okabayashi, M. Hanyu, Y. Soga, T. Nomoto, Y. Arai, T. Matsuo, M. Kai, and M. Kawatou Risk factors for wound infection after off-pump coronary artery bypass grafting: Should bilateral internal thoracic arteries be harvested in patients with diabetes? J. Thorac. Cardiovasc. Surg., March 1, 2008; 135(3): 540 - 545. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Martinez-Sanz, R. de la Llana, I. Nassar, and P. Garrido Use of Both Internal Thoracic Arteries in Diabetic Patients Ann. Thorac. Surg., February 1, 2008; 85(2): 690 - 690. [Full Text] [PDF] |
||||
![]() |
E. B. Savage Reply Ann. Thorac. Surg., February 1, 2008; 85(2): 690 - 690. [Full Text] [PDF] |
||||
![]() |
E. B. Savage Reply Ann. Thorac. Surg., November 1, 2007; 84(5): 1797 - 1797. [Full Text] [PDF] |
||||
![]() |
M. Boodhwani and F. D. Rubens Preserved Sternal Perfusion Following ITA Skeletonization: Implications for Bilateral ITA Grafting Ann. Thorac. Surg., November 1, 2007; 84(5): 1796 - 1797. [Full Text] [PDF] |
||||
![]() |
E. C. Douville Invited commentary Ann. Thorac. Surg., March 1, 2007; 83(3): 1007 - 1007. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |